These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28793824)

  • 1. Dual Therapy Deflazacort/Doxycyclyne Is Better Than Deflazacort Monotherapy to Alleviate Cardiomyopathy in Dystrophin-Deficient mdx Mice.
    Pereira JA; Mauricio AF; Marques MJ; Neto HS
    J Cardiovasc Pharmacol Ther; 2017 Sep; 22(5):458-466. PubMed ID: 28793824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-administration of deflazacort and doxycycline: a potential pharmacotherapy for Duchenne muscular dystrophy.
    Pereira JA; Marques MJ; Santo Neto H
    Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):788-94. PubMed ID: 25959722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suramin attenuates dystrophin-deficient cardiomyopathy in the mdx mouse model of duchenne muscular dystrophy.
    De Oliveira Moreira D; Pereira JA; Taniguti AP; Matsumura CY; Ramos LA; Areas MA; Neto HS; Marques MJ
    Muscle Nerve; 2013 Dec; 48(6):911-9. PubMed ID: 23536447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term therapy with deflazacort decreases myocardial fibrosis in mdx mice.
    Marques MJ; Oggiam DS; Barbin IC; Ferretti R; Santo Neto H
    Muscle Nerve; 2009 Sep; 40(3):466-8. PubMed ID: 19623634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uniform low-level dystrophin expression in the heart partially preserved cardiac function in an aged mouse model of Duchenne cardiomyopathy.
    Wasala NB; Yue Y; Vance J; Duan D
    J Mol Cell Cardiol; 2017 Jan; 102():45-52. PubMed ID: 27908661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-RANKL Therapy Prevents Glucocorticoid-Induced Bone Loss and Promotes Muscle Function in a Mouse Model of Duchenne Muscular Dystrophy.
    Jayash SN; Hamoudi D; Stephen LA; Argaw A; Huesa C; Joseph S; Wong SC; Frenette J; Farquharson C
    Calcif Tissue Int; 2023 Oct; 113(4):449-468. PubMed ID: 37470794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EPA protects against muscle damage in the mdx mouse model of Duchenne muscular dystrophy by promoting a shift from the M1 to M2 macrophage phenotype.
    Carvalho SC; Apolinário LM; Matheus SM; Santo Neto H; Marques MJ
    J Neuroimmunol; 2013 Nov; 264(1-2):41-7. PubMed ID: 24090650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of plasma interleukins as biomarkers for deflazacort and omega-3 based Duchenne muscular dystrophy therapy.
    de Carvalho SC; Matsumura CY; Santo Neto H; Marques MJ
    Cytokine; 2018 Feb; 102():55-61. PubMed ID: 29276972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term administration of pirfenidone improves cardiac function in mdx mice.
    Van Erp C; Irwin NG; Hoey AJ
    Muscle Nerve; 2006 Sep; 34(3):327-34. PubMed ID: 16770778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy.
    Dubinin MV; Talanov EY; Tenkov KS; Starinets VS; Belosludtseva NV; Belosludtsev KN
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane sealant Poloxamer P188 protects against isoproterenol induced cardiomyopathy in dystrophin deficient mice.
    Spurney CF; Guerron AD; Yu Q; Sali A; van der Meulen JH; Hoffman EP; Nagaraju K
    BMC Cardiovasc Disord; 2011 May; 11():20. PubMed ID: 21575230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in calsequestrin, TNF-α, TGF-β and MyoD levels during the progression of skeletal muscle dystrophy in mdx mice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles.
    Barros Maranhão J; de Oliveira Moreira D; Maurício AF; de Carvalho SC; Ferretti R; Pereira JA; Santo Neto H; Marques MJ
    Int J Exp Pathol; 2015 Oct; 96(5):285-93. PubMed ID: 26515458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart.
    Yue Y; Li Z; Harper SQ; Davisson RL; Chamberlain JS; Duan D
    Circulation; 2003 Sep; 108(13):1626-32. PubMed ID: 12952841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent and improved functional gain in mdx dystrophic mice after treatment with L-arginine and deflazacort.
    Archer JD; Vargas CC; Anderson JE
    FASEB J; 2006 Apr; 20(6):738-40. PubMed ID: 16464957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy.
    Adamo CM; Dai DF; Percival JM; Minami E; Willis MS; Patrucco E; Froehner SC; Beavo JA
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19079-83. PubMed ID: 20956307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin provides long-term improvement of left ventricular function and prevents cardiac fibrosis in muscular dystrophy.
    Kim MJ; Bible KL; Regnier M; Adams ME; Froehner SC; Whitehead NP
    Physiol Rep; 2019 Mar; 7(6):e14018. PubMed ID: 30912308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice hearts at later stages of dystrophy.
    Fogagnolo Mauricio A; Pereira JA; Santo Neto H; Marques MJ
    Nutrition; 2016; 32(7-8):855-62. PubMed ID: 27134205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dystrophin levels in heart can delay heart failure in mdx mice.
    van Putten M; van der Pijl EM; Hulsker M; Verhaart IE; Nadarajah VD; van der Weerd L; Aartsma-Rus A
    J Mol Cell Cardiol; 2014 Apr; 69():17-23. PubMed ID: 24486194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
    Griggs RC; Miller JP; Greenberg CR; Fehlings DL; Pestronk A; Mendell JR; Moxley RT; King W; Kissel JT; Cwik V; Vanasse M; Florence JM; Pandya S; Dubow JS; Meyer JM
    Neurology; 2016 Nov; 87(20):2123-2131. PubMed ID: 27566742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timeline of cardiac dystrophy in 3-18-month-old MDX mice.
    Van Erp C; Loch D; Laws N; Trebbin A; Hoey AJ
    Muscle Nerve; 2010 Oct; 42(4):504-13. PubMed ID: 20589894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.